Article
A functional Notch–survivin gene signature in basal breast cancer
24 Nov 2008
Abstract excerpt
INTRODUCTION: Basal-type, or triple-negative, breast cancer (lacking estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2 expression) is a high-risk disease for which no molecular therapies are currently available. We studied genetic signatures of basal breast cancer potentially suitable for therapeutic intervention. METHODS: We analyzed protein expression of the Notch-1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
